首頁 > 市場調查報告書 > 製藥

基因治療學和RNAi

市場調查報告書

商品編碼

1547544

全球 DNA 聚合酶市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

Global DNA Polymerase Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 170 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

預計到 2032 年，全球 DNA 聚合酶市場需求將從 2023 年的 1.6756 億美元達到近 1.9709 億美元的市場規模，2024-2032 年研究期間複合年成長率為 1.82%。

DNA聚合酶是指將DNA鏈上的核苷酸組裝在一起所需的酵素。它是 DNA 複製的必需酵素。對於每次細胞分裂，DNA 聚合酶對於細胞 DNA 的複製是必需的。正是透過這種方式，遺傳資料才從一代傳給另一代。 DNA 聚合酶透過在新 DNA 鏈的 3' 端添加新核苷酸來發揮作用。 DNA 聚合酶也透過稱為「校對」的過程來幫助糾正新合成鏈中的錯誤。在此過程中，錯誤的耦合被識別並透過反轉一個鹼基對的方向來修正。有缺陷的部分透過稱為切除的過程進一步去除。 DNA 聚合酶對於轉錄和翻譯過程至關重要，從而導致蛋白質合成。

市場動態

由於其在生物製藥、法醫學、診斷中心、研究中心等行業的使用，DNA聚合酶的市場需求在過去幾十年中不斷增加。增加預計該市場將出現高成長。根據世界衛生組織的數據，癌症死亡人數預計在十年內將增加近 70%。此外，用於治療慢性疾病的重組藥物數量的不斷增加將推動DNA聚合酶的市場成長。全球犯罪事件的增加預計也將導致 DNA 聚合酶在法醫學中的使用增加。高成本、道德問題和嚴格的法規核准可能會影響研究期間的市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球 DNA 聚合酶市場的各個細分市場進行了包容性評估。 DNA 聚合酶產業的成長和趨勢為本研究提供了整體方法。

市場區隔

DNA 聚合酶市場報告的這一部分提供了國家和地區層面細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按類型

Taq聚合酶
Pfu聚合酶
專有酵素混合物
其他

按申請

聚合酶鍊式反應
DNA定序
DNA克隆
其他

按最終用途

製藥和生物技術公司
學術及研究機構
醫院和診斷中心
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲 DNA 聚合酶市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。 DNA聚合酶市場的主要參與者包括Thermo Fisher Scientific Inc.、Agilent Technologies、Merck KGaA、Danaher、QIAGEN、Hoffmann-La Roche Ltd、Bio-Rad Laboratories Inc.、Takara Bio Inc.、Promega Corporation、New England Biolabs。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：DNA 聚合酶公司的競爭格局

DNA聚合酶市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

頂級公司市佔率分析
市場集中度
Thermo Fisher Scientific Inc.

公司概況
公司收入
產品
最新動態

Agilent Technologies

公司概況
公司收入
產品
最新動態

Merck KGaA

公司概況
公司收入
產品
最新動態

Danaher

公司概況
公司收入
產品
最新動態

QIAGEN

公司概況
公司收入
產品
最新動態

Hoffmann-La Roche Ltd

公司概況
公司收入
產品
最新動態

Bio-Rad Laboratories Inc.

公司概況
公司收入
產品
最新動態

Takara Bio Inc.

公司概況
公司收入
產品
最新動態

Promega Corporation

公司概況
公司收入
產品
最新動態

New England Biolabs

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11215008

The global demand for DNA Polymerase Market is presumed to reach the market size of nearly USD 197.09 Million by 2032 from USD 167.56 Million in 2023 with a CAGR of 1.82% under the study period 2024-2032.

DNA polymerase refers to an enzyme that is required for assembling the nucleotides together on the DNA strand. It is an essential enzyme for DNA replication. For each cell division, DNA polymerase is mandatory for the replication of the cell's DNA. It is through this that the genetic data is passed from one generation to the other. DNA polymerase functions by adding a new nucleotide at the 3' end of the new DNA strand. DNA polymerase also assists in correcting the mistakes in the newly synthesized strand by the process known as 'proofreading.' In this process, the incorrect coupling is recognized and rectified by reversing the direction by one base pair. The faulty part is further removed by the process called excision. DNA polymerase is vital for the process of transcription and translation, which results in protein synthesis.

MARKET DYNAMICS

The DNA polymerase market demand has increased over the past few decades due to its use in industries such as biopharma, forensic science, diagnostic centers, research centers etc. In addition, with in the increasing incidences of cancer, neurological disorders, genetic mutation and chronic diseases a high growth is anticipated in the this market. As per WHO, the number of deaths due to cancer is expected to increase by close to 70% over the decade. Also,the rising number of recombinant medicines used in treating chronic diseases will boost the market growth of DNA polymerase. Rising incidents of crimes across the globe is also expected to lead to higher usage of DNA polymerase in forensic science. High cost, ethical issues, and stringent regulatory approvals may impact the market growth under the study period.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of DNA Polymerase. The growth and trends of DNA Polymerase industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the DNA Polymerase market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

Taq Polymerase
Pfu Polymerase
Proprietary Enzyme Blends
Others

By Application

Polymerase Chain Reaction
DNA Sequencing
DNA Cloning
Others

By End-use

Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Hospitals & Diagnostic Centers
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the DNA Polymerase market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the DNA Polymerase market include Thermo Fisher Scientific Inc., Agilent Technologies, Merck KGaA, Danaher, QIAGEN, Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc., Takara Bio Inc., Promega Corporation, New England Biolabs. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. DNA POLYMERASE - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-use
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL DNA POLYMERASE MARKET ANALYSIS BY TYPE

5.1. Overview By Type
5.2. Historical and Forecast Data
5.3. Analysis By Type
5.4. Taq Polymerase Historic and Forecast Sales By Regions
5.5. Pfu Polymerase Historic and Forecast Sales By Regions
5.6. Proprietary Enzyme Blends Historic and Forecast Sales By Regions
5.7. Others Historic and Forecast Sales By Regions

6. GLOBAL DNA POLYMERASE MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data
6.3. Analysis By Application
6.4. Polymerase Chain Reaction Historic and Forecast Sales By Regions
6.5. DNA Sequencing Historic and Forecast Sales By Regions
6.6. DNA Cloning Historic and Forecast Sales By Regions
6.7. Others Historic and Forecast Sales By Regions

7. GLOBAL DNA POLYMERASE MARKET ANALYSIS BY END-USE

7.1. Overview By End-use
7.2. Historical and Forecast Data
7.3. Analysis By End-use
7.4. Pharmaceutical and Biotechnology Companies Historic and Forecast Sales By Regions
7.5. Academic and Research Institutes Historic and Forecast Sales By Regions
7.6. Hospitals & Diagnostic Centers Historic and Forecast Sales By Regions
7.7. Others Historic and Forecast Sales By Regions

8. GLOBAL DNA POLYMERASE MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE DNA POLYMERASE COMPANIES

9.1. DNA Polymerase Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF DNA POLYMERASE INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Thermo Fisher Scientific Inc.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Agilent Technologies
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Merck KGaA
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Danaher
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. QIAGEN
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Hoffmann-La Roche Ltd
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Bio-Rad Laboratories Inc.
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Takara Bio Inc.
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Promega Corporation
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. New England Biolabs
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments